All Stories

  1. Trichoscopic Diagnosis of Structural Hair Defects in a Clinical Setting: A Cross-Sectional Analytical Study
  2. From the Cochrane Library: Interventions for Acne Scars
  3. From the Cochrane Library: Interventions for Acne Scars (Preprint)
  4. Trichoscopic features of hair and scalp in noncomplaining individuals: A descriptive study
  5. Tranexamic acid versus fractional carbon dioxide laser in post‐acne hyperpigmentation
  6. Trichoscopy as an evaluation method for alopecia areata treatment: A comparative study
  7. Dermoscopy as a useful tool for evaluating melasma and assessing the response to 1064‐nm Q‐switched Nd: YAG laser
  8. The efficacy of intra dermal injections of botulinum toxin in management of enlarged facial pores and seborrhea: A split face controlled study
  9. Cyclooxygenase-2 Gene Polymorphisms –765G>C and –1195A>G and Mycosis Fungoides Risk
  10. Elevated serum tumour necrosis factor‐like weak inducer of apoptosis in alopecia areata: a possible marker of disease severity
  11. Tissue lipocalin-2 in psoriasis: is it a marker of metabolic disturbance or a possible marker of therapeutic efficacy after narrow band ultraviolet B?
  12. Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis
  13. Interventions for cutaneous sarcoidosis
  14. Clinical and dermoscopic evaluation of combined (salicylic acid 20% and azelaic acid 20%) versus trichloroacetic acid 25% chemical peel in acne: a RCT
  15. Toenail concentrations of zinc, selenium and nickel in patients with chronic recurrent warts: A pilot two-group comparative study
  16. Do prolactin and its receptor play a role in alopecia areata?
  17. Interleukin-17 · Nonsegmental vitiligo · Vitamin D
  18. Studying the association between methylenetetrahydrofolate reductase (MTHFR) 677 gene polymorphism, cardiovascular risk and lichen planus
  19. Low level light-minoxidil 5% combination versus either therapeutic modality alone in management of female patterned hair loss: A randomized controlled study
  20. Higher Expression of Toll-like Receptors 3, 7, 8, and 9 in Pityriasis Rosea
  21. Can teledermatology be a useful diagnostic tool in dermatology practice in remote areas? An Egyptian experience with 600 patients
  22. Toll-like receptor (TLR)7 expression in mycosis fungoides and psoriasis: a case-control study
  23. Assessment of cubosomal alpha lipoic acid gel efficacy for the aging face: a single-blinded, placebo-controlled, right-left comparative clinical study
  24. Association of interleukin (IL)18 and IL10 gene polymorphisms with oral lichen planus risk; a case-control study
  25. Interventions for acne scars
  26. Propranolol versus captopril in the treatment of infantile hemangioma (IH): A randomized controlled trial
  27. B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata
  28. Dermoscopic and Immunohistochemical Changes in Acquired Melanocytic Nevi following Narrow-Band Ultraviolet B Therapy
  29. Interventions for acne scars
  30. Assessment of gene expression levels of proopiomelanocortin (POMC) and melanocortin-1 receptor (MC1R) in vitiligo
  31. Treatment of dystrophic epidermolysis bullosa with bone marrow non-hematopoeitic stem cells: a randomized controlled trial
  32. Nail dermoscopy is a helpful tool in the diagnosis of onychomycosis: A case control study
  33. Association of Angiotensin-Converting Enzyme (ACE) Gene Polymorphism with Inflammation and Cellular Cytotoxicity in Vitiligo Patients
  34. Combination of Radiofrequency and Intralesional Steroids in the Treatment of Keloids
  35. Séances alternatives du laser fractionné 1540 nm et l’induction percutanée du collagène avec de l’acide trichloracétique à 20 % concentration dans le traitement de cicatrices d’acné atrophiques ? Un essai contrôlé randomisé
  36. Assessment of Tissue Level of Histone Deactylase-2 (HDAC-2) in Patients With Mycosis Fungoides
  37. Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial
  38. Interventions for guttate psoriasis
  39. Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus
  40. Reduction in tissue plasmin: a new mechanism of action of narrowband ultraviolet B in psoriasis
  41. Study of T helper 1 and T helper 2 responses in pemphigus vulgaris patients receiving interferon alpha 2a injections in addition to a standard protocol therapy: a randomized controlled trial
  42. Kallin syndrome associated with vitiligo
  43. Expression of osteopontin genotypes (T-4754-C and A-9138-C) in psoriasis and their relation to metabolic syndrome
  44. Erratum to: Efficacy and safety of fractional carbon dioxide laser for treatment of unwanted facial freckles in phototypes II–IV: a pilot study
  45. The Pro12Ala polymorphism of the gene for peroxisome proliferator activated receptor-gamma is associated with a lower Global Acne Grading System score in patients with acne vulgaris
  46. Study of T helper (17) and T regulatory cells in psoriatic patients receiving live attenuated varicella vaccine therapy in a randomized controlled trial
  47. Efficacy and safety of fractional carbon dioxide laser for treatment of unwanted facial freckles in phototypes II–IV: a pilot study
  48. The efficacy of intralesional cryosurgery in the treatment of small- and medium-sized basal cell carcinoma: A pilot study
  49. Medical ethical standards in dermatology: an analytical study of knowledge, attitudes and practices
  50. Interventions for cutaneous sarcoidosis
  51. Mycophenolate mofetil: a novel immunosuppressant in the treatment of dystrophic epidermolysis bullosa, a randomized controlled trial
  52. Clinical study of nail changes in vitiligo
  53. The role of interleukin-1ß and interleukin-33 in atopic dermatitis
  54. Serum Ferritin and Vitamin D in Female Hair Loss: Do They Play a Role?
  55. The Antioxidant Role of Paraoxonase 1 and Vitamin E in Three Autoimmune Diseases
  56. Hypopigmented parapsoriasis en plaque, a new, overlooked member of the parapsoriasis family: A report of 34 patients and a 7-year experience
  57. Non-ablative 1540 fractional laser: How far could it help injection lipolysis and dermal fillers in lower-face rejuvenation? a randomized controlled trial
  58. Psoriasis and metabolic syndrome: Is peroxisome proliferator-activated receptor-γ part of the missing link?
  59. The efficacy of laser-assisted hair removal in the treatment of acne keloidalis nuchae; a pilot study
  60. Do combined alternating sessions of 1540 nm nonablative fractional laser and percutaneous collagen induction with trichloroacetic acid 20% show better results than each individual modality in the treatment of atrophic acne scars? A randomized controlle...
  61. Reduction of RANTES expression in lesional psoriatic skin after narrow band ultraviolet therapy: a possible marker of therapeutic efficacy
  62. Deep peeling using phenol versus percutaneous collagen induction combined with trichloroacetic acid 20% in atrophic post-acne scars; a randomized controlled trial
  63. Intralesional cryosurgery and intralesional steroid injection: a good combination therapy for treatment of keloids and hypertrophic scars
  64. Live attenuated varicella vaccine: A new effective adjuvant weapon in the battlefield against severe resistant psoriasis, a pilot randomized controlled trial
  65. Association between the angiotensin-converting enzyme gene insertion/deletion polymorphism and the risk for psoriasis
  66. Effect of narrow band ultraviolet B on survivin in psoriatic skin lesions
  67. DNA polymorphisms and tissue cyclooxygenase-2 expression in oral lichen planus: a case-control study
  68. Association between the leptin gene 2548G/A polymorphism, the plasma leptin and the metabolic syndrome with psoriasis
  69. Clinical study of nail changes in leprosy and comparison with nail changes in diabetic patients
  70. Percutaneous Collagen Induction Versus Full-Concentration Trichloroacetic Acid in the Treatment of Atrophic Acne Scars
  71. The possible role of trauma in skin tags through the release of mast cell mediators
  72. Skin tags, leptin, metabolic syndrome and change of the life style
  73. Psoriasis
  74. Expression of cyclin D1 and p16 in psoriasis before and after phototherapy
  75. Thymus and activation-regulated chemokine in different stages of mycosis fungoides: Tissue and serum levels
  76. Increased tissue leptin hormone level and mast cell count in skin tags: A possible role of adipoimmune in the growth of benign skin growths
  77. Different therapeutic modalities for treatment of melasma
  78. The use of sulfasalazine and pentoxifylline (low-cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study